A new blood glucose management algorithm for type 2 diabetes.

The article offers information on the position statement of Australian Diabetes Society (ADS) which describes the place of various drug classes in management algorithm for lowering blood glucose level (BGL) in type 2 diabetes (T2D) patients. Topics discussed include glycaemic targets individualisation, treatment approaches, and glucose-lowering therapy in older people and those with renal or hepatic impairment.